Co-leader, Cancer Outcomes and Survivorship Research Program (developing program)
Section Chief, Pediatric Hematology and Oncology
Professor, Department of Pediatrics

jneglia@umn.edu
612-626-2778 — office
Preferred method of contact: Secretary: Linda DeVoe devoe001@umn.edu or 612-626-2778

Dr. Neglia's clinical profile
(University of Minnesota Physicians Web site)

Dr. Neglia is section chief of Pediatric Hematology and Oncology and a professor in the Department of Pediatrics Division of Pediatric Hematology/Oncology/Blood and Marrow Transplantation. He received his M.D. degree in 1981 from Loma Linda University School of Medicine and was a pediatric intern, resident, and chief resident at the Baylor College of Medicine in Houston, Texas. He came to the University of Minnesota in 1984 to pursue a fellowship in Pediatric Hematology/Oncology and Blood and Marrow Transplantation. During his fellowship, Dr. Neglia received a master's degree in public health in epidemiology. Following his fellowship, he was an instructor in the Department of Pediatrics (1987), promoted to assistant professor in 1988, associate professor in 1992, and full professor in 2002. He has a joint appointment in the Division of Epidemiology and Community Health in the School of Public Health.

Research Interests

Dr. Neglia is widely recognized for his research into the long-term outcomes of childhood cancer survivors. He has focused on the occurrence of second malignancies across the childhood cancer population and specifically on the long-term outcomes of childhood acute lymphoblastic leukemia (ALL) survivors. Dr. Neglia is currently the principal investigator of an American Cancer Society Research Scholar Grant studying the neurobehavioral outcomes of ALL survivors and the principal investigator of a Lance Armstrong Foundation Grant investigating communication strategies in adolescent and young adult cancer survivors. Dr. Neglia is the chair of the ALL Outcomes committee of the Children's Oncology Group and a member of the steering committee of the Childhood Cancer Survivor Study.

Selected Publications

Sigurdson AJ, Ronckers CM, Mertens AC, Stovall M, Smith SA, Liu Y, Berkow RL, Hammond S, Neglia JP, Meadows AT, Sklar CA, Robison LL, Inskip PD. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study. Lancet. 2005;365:2014-2023.

Perkins JL, Liu Y, Mitby PA, Neglia JP, Hammond S, Stovall M, Meadows AT, Hutchinson R, Dreyer ZE, Robison LL, Mertens AC. Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2005; 23:3733-3741.

Schultz KA, Sencer SF, Messinger Y, Neglia JP, Steiner ME. Pediatric ovarian tumors: a review of 67 cases. Pediatr Blood Cancer. 2005;44:167-173.

Kumar A, Saltzman D, Shukula M, Lewis V, Wendorf R, Sauer M, Neglia J, Baker KS, Macmillan M, Steiner ME. Diagnostic peritoneal lavage for assessing acute abdomen in pediatric oncology and stem cell transplantation patients. J Pediatr Hematol Oncol. 2004;26:824-826.

Kenney LB, Yasui Y, Inskip PD, Hammond S, Neglia JP, Mertens AC, Meadows AT, Friedman D, Robison LL, Diller L. Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med. 2004;141:590-597.

Bassal M, Mertens AC, Taylor L, Neglia JP, Greffe BS, Hammond S, Ronckers CM, Friedman DL, Stovall M, Yasui YY, Robison LL, Meadows AT, Kadan-Lottick NS: The risk of selected subsequent carcinomas in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Clin Onc. 2006;24:476-483.

Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, Mertens AC, Liu Y, Hammond S, Land CE, Neglia JP, Meadows AT, Sklar CA, Robison LL and Inskip PD: Thyroid Cancer in Childhood Cancer Survivors: A Detailed Evaluation of Radiation Dose-Response and its Modifiers. Radiation Research, 166:618-628, 2006.

Neglia JP, Robison LL, Stoval M, Liu Y, Packer RJ, Hammond S, Yasui Y, Kasper CE, Mertens AC, Donaldson SS, Meadows AT, Inskip PD. New Primary Neoplasms of the Central Nervous System in Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study. Journal of the National Cancer Institute, 98(21):1528-37, 2006.

Weigel B, Adamson P, Blaney S, Bagatell R, Whitesell L, Kersey, J, Neglia J, Percy I , Krailo, M, Reid J, Ames, M, Gilbertson R: A Phase I Study of 17-allylaminogeldanamycin (17-AAG) in Relapsed/Refractory Pediatric Patients with Solid Tumors: A Children's Oncology Group Study. Clinical Cancer Research, 13(6):1789-1793, 2007.

Al-Sweedan SA, Neglia JP, Steiner ME, Bostrom BC, Casey T, Hirsch BA. Characteristics of patients with TEL-AML1-positive acute lymphoblastic leukemia with single or multiple fusions. Pediatric Blood and Cancer, 5:510-514, 2007.

Henderson T, Whitton J, Stovall M, Mertens A, Mitby P, Friedman D, Strong L, Hammond S, Neglia J, Meadows A, Robison L, Diller L. Secondary Sarcomas in Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor Study. Journal of the National Cancer Institute, 99:300-308, 2007.

Mulrooney DA, Ness KK, Neglia JP, Whitton JA, Green DM, Zeltzer LK, Robison L, Mertens AC: Fatigue and Sleep Disturbance in Adult Survivors of Childhood Cancer. A Report from the Childhood Cancer Survivor Study (CCSS). Sleep, 31:271-280, 2008.